Vaccines market was estimated to be over US$ 36,297.2 million in 2019. It is anticipated to grow at a CAGR of 6.0% from 2019 to 2030.
Several factors can be attributed to the growth of the global vaccines market, such as advancements in vaccine production technology, growing population, rising initiatives by government bodies across the globe to promote vaccinations, and robust vaccine pipeline by major players, among others. One of the major factors which has been responsible for the growth of this market is the outbreak of infectious diseases in different regions. For instance, the declaration of Polio outbreak in Philippines in 2019 and eradication of Measles from U.S. are few instances when an outbreak of certain infectious diseases has or had a positive impact on the global vaccines market. Similarly, the current COVID-19 pandemic has triggered the need for therapeutic & preventive solutions, such as vaccines, to put an end to this life-threatening disease. Companies around the world are coming together to develop a novel vaccine against the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). For instance, on April 14, 2020, two major players in the global vaccines market, viz. Sanofi and GSK announced that the companies have signed a letter of intent to enter into a collaboration to develop an adjuvanted vaccine for COVID-19, using innovative technology from both companies, to help address the ongoing pandemic.
Major Key Players of the Vaccines Market are:Pfizer, GlaxoSmithKline, Merck & Co., Sanofi Pasteur Limited (Sanofi), AstraZeneca, CSL Limited, Bavarian Nordic, Panacea Biotec Limited, PT Bio Farma (Persero) and Serum Institute of India Pvt. Ltd. among others
Read More @ https://www.openpr.com/news/2020173/vaccines-market-forecasts-to-2030-regional-development
Several factors can be attributed to the growth of the global vaccines market, such as advancements in vaccine production technology, growing population, rising initiatives by government bodies across the globe to promote vaccinations, and robust vaccine pipeline by major players, among others. One of the major factors which has been responsible for the growth of this market is the outbreak of infectious diseases in different regions. For instance, the declaration of Polio outbreak in Philippines in 2019 and eradication of Measles from U.S. are few instances when an outbreak of certain infectious diseases has or had a positive impact on the global vaccines market. Similarly, the current COVID-19 pandemic has triggered the need for therapeutic & preventive solutions, such as vaccines, to put an end to this life-threatening disease. Companies around the world are coming together to develop a novel vaccine against the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). For instance, on April 14, 2020, two major players in the global vaccines market, viz. Sanofi and GSK announced that the companies have signed a letter of intent to enter into a collaboration to develop an adjuvanted vaccine for COVID-19, using innovative technology from both companies, to help address the ongoing pandemic.
Major Key Players of the Vaccines Market are:Pfizer, GlaxoSmithKline, Merck & Co., Sanofi Pasteur Limited (Sanofi), AstraZeneca, CSL Limited, Bavarian Nordic, Panacea Biotec Limited, PT Bio Farma (Persero) and Serum Institute of India Pvt. Ltd. among others
Read More @ https://www.openpr.com/news/2020173/vaccines-market-forecasts-to-2030-regional-development
No comments:
Post a Comment